15 Insights on

• Enhanced Immune Response After IBDV Vaccination
• Reduced Odor-Causing Compound Concentrations
• Enhanced Immune Response Following IBDV Vaccination
• Increased Relative Weight of Immune Organs
• Alleviated Organ Injury
• Improved Immune Response
• Enhanced Immune Response to Vaccine for Infectious Bursal Disease Virus (IBDV)
• Improved Growth Performance
• Alleviated Organ Injury from E. coli O78
• Improved Immune Organ Development
• Increased Organ Weights
• Reduced Organ Injury
• Reduced Organ Injury from Heat Stress
• Alleviated Organ Injury from Heat Stress
• Reduced Organ Injury from Escherichia coli

5 Insights on

• Reduced Tannerella forsythia in Subgingival Plaque
• Improved Periodontal Health
• Reduced Periodontopathic Bacteria
• Reduced Pathogenic Bacteria
• Reduced Tannerella Forsythia Levels

14 Insights on

• Increased Gut Lactobacilli Levels
• Improved Gut Microbiome Composition
• Increased Gut Lactobacilli Counts
• Reduced Triglyceride Levels
• Improved Insulin Sensitivity
• Improved Gut Microbiota Composition
• Reduced LDL Cholesterol
• Reduced Inflammatory Response
• Increased HDL Cholesterol Levels
• Improved Serum Lipids
• Increased Fecal Lactobacilli
• Improved Lipid Profile
• Improved Gut Lactobacilli Count
• Reduced Total Cholesterol Levels

26 Insights on

• Improved Antioxidant Enzyme Levels
• Increased Antioxidant Enzyme Levels
• Increased Expression of Oxidation-related Gene HO-1
• Reduced Pro-Inflammatory Cytokines
• Reduced Inflammatory Response
• Reduced Diarrhea Incidence
• Increased Intestinal Tight Junction Protein Expression
• Reduced Serum D-Lactate Levels
• Increased Serum Anti-inflammatory Cytokines
• Increased Tight Junction Protein Levels
• Reduced Pro-inflammatory Mediator Levels
• Increased Expression of Oxidation-Related Gene
• Regulated Immune Response
• Reduced Diarrhea Rate
• Reduced Interleukin-6 Levels
• Enhanced Antioxidant Activity
• Increased Anti-inflammatory Cytokines
• Increased Tight Junction Proteins (Claudin-1)
• Reduced Proinflammatory Mediators
• Reduced Levels of Pro-Inflammatory Cytokines (IL-1β, IL-6, IFN-γ, TNF-α)
• Improved Tight Junction Protein Expression
• Improved Intestinal Barrier Function
• Reduced Pro-Inflammatory Mediator Production
• Regulated Oxidative Stress
• Increased Anti-Inflammatory Cytokine Levels
• Improved Growth Performance

14 Insights on

• Increased Villus Height
• Increased Beneficial Gut Bacteria
• Improved Duodenum Villus Height
• Improved Villus Height in Duodenum
• Improved Gut Morphology
• Increased Duodenal Villus Height
• Improved Abundance of Beneficial Bacteria
• Increased Lactobacillus Counts
• Reduced Abundance of Harmful Bacteria
• Improved Lactobacillus Abundance
• Improved Intestinal Villus Height
• Increased Fecal Lactobacilli
• Improved Gut Microbiota Diversity
• Improved Villus Height

33 Insights on

• Increased Fecal Bifidobacteria
• Increased Risk of Necrotizing Enterocolitis Stage 2 or Higher
• Increased Fecal Immunoglobulin A Concentrations
• No Change in Risk of Necrotizing Enterocolitis
• Reduced Faecal pH
• No Reduction in Antibiotic Use
• Increased Fecal Immunoglobulin A Levels
• No Adverse Events Associated with B Lactis Supplementation
• Reduced Stool pH
• Reduced Enterobacteriaceae Counts
• Absence of Adverse Events
• No Change in Sepsis Risk
• Reduced Intestinal Permeability
• No Change in Risk of Stage 2 or Higher Necrotizing Enterocolitis
• No Change in Risk of Necrotizing Enterocolitis Stage 2 or Higher
• Adverse Events Due to Supplementation
• Increased Fecal Bifidobacteria Levels
• Reduced Body Mass Index
• Increased Short Chain Fatty Acids
• Reduced Clostridium Species Counts
• Increased Antibiotic Use
• Unchanged Use of Antibiotics
• No Adverse Events Observed
• Reduced Fecal Calprotectin
• Unchanged Risk of Sepsis
• Increased Short-Chain Fatty Acids Concentrations
• Reduced Faecal Calprotectin
• Reduced Clostridium Counts
• Reduced Enterobacterial Counts
• No Reduced Risk of Necrotizing Enterocolitis
• Increased Risk of Sepsis
• No Change in Antibiotic Usage
• Increased Fecal Short-Chain Fatty Acid Concentrations

18 Insights on

• Suppressed Transition to Obesity
• Maintained Gut Microbiota Composition
• Improved Gut Microbiome Composition
• Increased Beneficial Gut Bacteria
• Increased Protective Fecal Bifidobacterial Diversity
• Regulated Microbiota Composition
• Improved Abundance of Beneficial Bacteria
• Maintained Prevotella-Dominant Gut Microbiota
• Optimized Gut Microbiota Composition
• Altered Gut Microbiota Composition
• Reduced Body Weight
• Reduced Firmicutes/Bacteroidetes Ratio
• Prevention of Obesity Transition
• Reduced Obesity
• Improved Obesity Metrics
• Reduced Risk of Obesity
• Increased Production of Short-Chain Fatty Acids by Gut Bacteria
• Reduced Gut Microbiota Disorder

7 Insights on

• Duration of Symptoms
• Reduced Total Infections
• Reduced Gastrointestinal Infections
• Reduced Antibiotic Use Due to Infections
• Reduced Mean Number of Infections per Child
• Reduced Respiratory Infections
• Reduced Day Care Absenteeism Due to Infections

1 Insight on

• Reduced Fat Deposition

3 Insights on

• Improved Immune System Dialog via EPS
• Increased Cytokine Production in Peripheral Blood Mononuclear Cells
• Stable Cytokine Levels in Gut-Associated Lymphoid Tissue

3 Insights on

• Increased Relative Abundance of Bifidobacterium Animalis
• Increased Abundance of Bifidobacterium animalis
• Increased Streptococcus Percentage

2 Insights on

• Improved General Health
• Improved Gut Microbiota

2 Insights on

• Reduced Body Fat
• Improved Metabolic Syndrome Biomarkers

13 Insights on

• Reduced Colitis Disease Activity
• Improved Disease Activity Index for DSS-Induced Colitis
• Improved Clinical Outcome in DSS-Induced Colitis
• Improved Clinical Outcomes in Colitis
• Improved Gastrointestinal Survival
• Reduced Disease Activity Index (DAI) Levels
• Enhanced Survival of Bifidobacterium lactis in Gastrointestinal Tract
• Improved Disease Activity Index Score
• Reduced Disease Activity Index in DSS-Induced Colitis
• Increased Regulatory T Cell Count
• Enhanced Regulatory T-Cells in Mesenteric Lymphoid Nodes
• Increased Regulatory T-Cells in Mesenteric Lymphoid Nodes
• Reduced Disease Activity Index in Colitis Model

4 Insights on

• Reduced Fat Accumulation
• Elevated Lactate Levels
• Increased Fecal Acetate Levels
• Enhanced SCFA Production

9 Insights on

• Reduced Lipid Levels
• Reduced Total Lipid Levels
• Enhanced Antioxidant Response
• Improved Satiety Response
• Improved Blood Lipid Metabolism
• Enhanced Antioxidant Enzyme Activity
• Regulated Tryptophan Metabolism
• Reduced Triglyceride Levels
• Enhanced Antioxidant Defense

19 Insights on

• Reduced TNF-α Levels
• Improved Cholesterol Profile
• Reduced Plasma Tumor Necrosis Factor-α Levels
• No Significant Effect on Glucose Metabolism
• Improved Cardiovascular Health
• Reduced Hepatic Oxidative Stress
• Reduced Incidence of Cardiovascular Disease
• Reduced Food Intake
• Increased Adiponectin Levels
• No Change in Serum Triglycerides
• Reduced Plasma Ghrelin Levels
• Reduced Body Weight
• Reduced Inflammatory Markers
• Reduced Plasma Malondialdehyde Levels
• Reduced Weight Gain
• Reduced Cardiovascular Dysfunction
• Reduced Total Cholesterol to HDL Cholesterol Ratio
• Reduced Serum Malondialdehyde Levels
• Reduced Tumor Necrosis Factor Alpha

1 Insight on

• Adherence to Mucosal Surfaces

5 Insights on

• Reduced Acute Diarrhea Incidence
• Reduced Duration of Diarrhea
• Reduced Duration of Diarrhea Episodes
• Reduced Incidence of Diarrhea
• Delayed Onset of First Diarrhea Episode

4 Insights on

• Increased Short-Chain Fatty Acids Production
• Improved Gut Microbiome Composition
• Improved Colon Histopathology
• Reduced Colitis Symptoms

6 Insights on

• Reduced Faecal pH
• Bifidobacterium-Dominated Preterm Gut Microbiota
• Increased Fecal Acetate Levels
• Increased Bifidobacterium Predominance
• Mature Gut Microbiota
• Reduced Abundance of Pathobionts

7 Insights on

• Reduced Depression Symptoms
• Reduced Bifidobacterium Counts
• Increased Bifidobacterium Levels
• Increased Bifidobacterium Counts
• Reduced Occurrence of Major Depressive Disorder
• Reduced Bifidobacterium and Lactobacillus Counts in Patients with MDD
• Reduced Lactobacillus Counts

2 Insights on

• Reduced Pro-inflammatory Cytokine Levels
• Unchanged IFN-γ Levels

4 Insights on

• Unchanged Colonic Transit Time
• Improved Colonic Transit Time
• Increased Adverse Events
• Reduced Colonic Transit Time

3 Insights on

• Reduced Minor Digestive Symptoms
• Improved Digestive Symptoms
• Reduced Digestive Symptoms

3 Insights on

• Improved Gastrointestinal Discomfort
• Reduced Digestive Symptoms
• Reduced Abdominal Discomfort

19 Insights on

• Reduced Candida albicans Colonization
• Reduced Pathogen Growth
• Increased Beneficial Gut Bacteria
• Increased Beneficial Gut Bacterial Population
• Enhanced Bile Salt Resistance
• Increased Survival in Acidic Environment
• Increased Intestinal Cell Adhesion
• Improved Survival in Acidic Conditions
• Reduced Colonization of C. albicans in Intestines Post-Infection
• Strong Adherence of HT-29 Cells
• Reduced Pathogen Colonization
• Reduced Intestinal Colonization of Candida albicans
• Improved Gut Microbiota Composition
• Reduced Pathogen Activity
• Enhanced Intestinal Epithelial Cell Adhesion
• Reduced Pathogenic Load
• Improved Gut Microbiota
• Intestinal Cell Adherence
• Reduced Pathogenic Microorganism Activity

9 Insights on

• Reduced TNF-α Levels
• Reduced Serum TNF-α Levels
• Reduced Hepatic Steatosis
• Reduced Plasma Lipopolysaccharide Levels
• Reduced Hepatic Neutral Lipids
• Reduced Serum IL-6 Levels
• Reduced Serum LPS Levels
• Reduced Serum TNF-Alpha Level
• Reduced IL-6 Levels

7 Insights on

• Improved Resistance to Common Cold
• Improved Positive Mood States
• Reduced Common Cold Incidence in Susceptible Populations
• Reduced Incidence of Common Cold
• Maintained Positive Mood Under Stress
• Improved Positive Mood Under Stress
• Improved Resistance to Infections

15 Insights on

• Reduced Intestinal Inflammation
• Increased Anti-Inflammatory Cytokine Levels
• Enhanced Colorectal Homeostasis
• Enhanced Endoplasmic Reticulum Stress Response
• Reduced Weight Loss
• Reduced Pro-Inflammatory Cytokines
• Reduced Inflammatory Response
• Improved Colitis Symptoms
• Protection Against Colitis
• Maintained Colorectal Homeostasis
• Reduced Colitis Symptoms
• Reduced LPS-Induced Inflammation
• Reduced Inflammatory Protein Activation
• Increased ER Stress-Associated Proteins
• Reduced Inflammation Levels